Colesevelam hydrochloride 3750 MG Powder for Oral Suspension [Welchol] — RxCUI 866907
RxNorm drug concept · Semantic branded drug
RxCUI 866907
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI866907
Official nameColesevelam hydrochloride 3750 MG Powder for Oral Suspension [Welchol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asWelchol 3.75 GM Powder for Oral Suspension; Welchol 3750 MG Powder for Oral Suspension
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)608 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Colesevelam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That depends on why your doctor prescribed it. If you have high LDL cholesterol, colesevelam helps pull that 'bad' cholesterol down by working inside your gut — it's never absorbed...
- What exactly is colesevelam supposed to do for me?
- Yes, timing really matters here. Colesevelam — whether you're taking the tablets or mixing the powder into a drink — should always be taken with a meal. The tricky part is that it...
- How do I take it, and does it matter when I take my other medications?
🕸️ Concept Web — How Colesevelam hydrochloride 3750 MG Powder for Ora... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Colesevelam hydrochloride 3750 MG Powder for Oral Suspension [Welchol]
RxCUI 866907 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Colesevelam
141626IN -
Colesevelam hydrochloride
141625PIN
-
Colesevelam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Welchol
284918BN
-
Welchol
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Colesevelam Powder for Oral Suspension
1870338SCDF -
Colesevelam hydrochloride Powder for Oral Suspension
2648674SCDFP -
Colesevelam Oral Powder Product
1870337SCDG -
Colesevelam Oral Product
1164984SCDG -
Colesevelam hydrochloride Oral Powder Product
2662961SCDGP -
Colesevelam hydrochloride Oral Product
2661751SCDGP -
Colesevelam Powder for Oral Suspension [Welchol]
1870341SBDF -
Colesevelam hydrochloride Powder for Oral Suspension [Welchol]
2656730SBDFP - +5 more in this family
-
Colesevelam Powder for Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Colesevelam hydrochloride 3750 MG Powder for Oral Suspension
866905SCD -
Colesevelam hydrochloride 3750 MG
1870336SCDC -
Colesevelam hydrochloride 3750 MG [Welchol]
1870340SBDC
-
Colesevelam hydrochloride 3750 MG Powder for Oral Suspension
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Colesevelam hydrochloride 3750 MG Powder for Oral Suspension
SCD · 866905 -
Colesevelam hydrochloride 3750 MG
SCDC · 1870336 -
Colesevelam Powder for Oral Suspension
SCDF · 1870338 -
Colesevelam hydrochloride Powder for Oral Suspension
SCDFP · 2648674 -
Colesevelam Oral Powder Product
SCDG · 1870337 -
Colesevelam Oral Product
SCDG · 1164984 -
Colesevelam hydrochloride Oral Powder Product
SCDGP · 2662961 -
Colesevelam hydrochloride Oral Product
SCDGP · 2661751
Brand-Name Concepts
-
Colesevelam hydrochloride 3750 MG [Welchol]
SBDC · 1870340 -
Colesevelam Powder for Oral Suspension [Welchol]
SBDF · 1870341 -
Colesevelam hydrochloride Powder for Oral Suspension [Welchol]
SBDFP · 2656730 -
Welchol Oral Powder Product
SBDG · 1870342 -
Welchol Oral Product
SBDG · 1187941 -
Welchol
BN · 284918
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 866907 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00713-0879-81 | 180 TABLET, FILM COATED in 1 BOTTLE (0713-0879-81) | Welchol | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 00713-0880-30 | 30 PACKET in 1 CARTON (0713-0880-30) / 1 FOR SUSPENSION in... | Welchol | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
Observed labelers:
Cosette Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.